Articles in this Cluster
29-09-2025
The article discusses how US President Donald Trump is taking action against high drug prices by issuing an executive order that requires pharmaceutical companies to peg their prices to the lowest charged in other rich countries. Trump has given leading pharma firms until September 29th to comply, threatening to use "every tool in our arsenal" against those that don't. The article questions whether Trump can succeed in his efforts to lower drug prices.
Entities: Donald Trump, America, Big Pharma, September 29th, most favoured nation (MFN) pricing • Tone: neutral • Sentiment: negative • Intent: inform
29-09-2025
The article disputes Donald Trump's claim that Tylenol (acetaminophen) is dangerous for children and linked to autism and ADHD. It argues that scientists have not reached firm conclusions on the link between Tylenol and these conditions, and that Trump's assertion is misguided. The article also highlights that Tylenol has real benefits as a pain-relieving drug.
Entities: Donald Trump, Tylenol, acetaminophen, paracetamol, autism • Tone: analytical • Sentiment: negative • Intent: inform
29-09-2025
The article analyzes Donald Trump's recent behavior and statements, suggesting that he feels more invincible than ever. Trump has become increasingly unfiltered in his comments, making controversial statements on various topics, including autism, immigration, and Ukraine. He has also shown a disregard for professional disapproval, treating it as evidence of authenticity. The article argues that Trump's behavior is consistent with his image as a challenger of conventions and a man above the normal consequences of politics, law, or diplomacy.
Entities: Donald Trump, United States, United Nations, Ukraine, Russia • Tone: negative • Sentiment: negative • Intent: analyze
